Instem has signed its largest ever single contract, a five-year $12m deal with
a leading global contract research organisation (CRO). The group is
deploying its new Aspire clinical trial acceleration solution to over 2,000
users worldwide. In our view, the contract win validates the group's growth
strategy and further demonstrates Instem’sinherent M&A ability. We leave
forecasts unchanged following this positive news, anticipating that the deal
will underpin our future projections.
05 Sep 2022
Instem: Largest ever contract validates growth strategy
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Instem: Largest ever contract validates growth strategy
- Published:
05 Sep 2022 -
Author:
Gareth Evans | Blaine Tatum -
Pages:
3
Instem has signed its largest ever single contract, a five-year $12m deal with
a leading global contract research organisation (CRO). The group is
deploying its new Aspire clinical trial acceleration solution to over 2,000
users worldwide. In our view, the contract win validates the group's growth
strategy and further demonstrates Instem’sinherent M&A ability. We leave
forecasts unchanged following this positive news, anticipating that the deal
will underpin our future projections.